Furthermore, the GPR44/DP2 antagonist AZD1981 had no significant effect on the paracetamol profile and thus gastric emptying in T2DM patients, which could have confounded the interpretation of MMTT data. This evidence concerns the gene PTGDR2 and type 2 diabetes mellitus.